Related Experiment Videos
Bone minerals in beta-thalassemia minor
J Kalef-Ezra1, A Challa, N Chaliasos
1Department of Medical Physics, Medical School, University of Ioannina, Greece.
Bone
|June 1, 1995
Summary
Beta-thalassemia minor, a genetic blood disorder, does not increase the risk of osteoporosis. Bone mineral density and metabolism markers were similar in patients and healthy individuals.
Area of Science:
- Hematology
- Endocrinology
- Orthopedics
Background:
- Homozygous beta-thalassemia is linked to osteopenia.
- Recent suggestions proposed beta-thalassemia minor as a potential osteoporosis risk factor.
Purpose of the Study:
- To investigate the potential association between beta-thalassemia minor and osteoporosis risk.
- To assess bone mineral status and metabolism in individuals with beta-thalassemia minor.
Main Methods:
- Evaluated 22 premenopausal women and 21 men with beta-thalassemia minor.
- Measured hand-bone phosphorus (HBP), forearm bone mineral content (BMC), and spinal bone mineral density (BMD) using various techniques.
- Assessed biochemical markers of bone metabolism, including serum calcium, phosphate, alkaline phosphatase, osteocalcin, parathyroid hormone, and urine calcium-to-creatinine ratio.
Main Results:
- No statistically significant differences in HBP, BMC, or BMD were found between beta-thalassemia minor subjects and matched healthy controls for either sex.
- Biochemical markers of bone metabolism also showed no significant differences between the study groups.
Conclusions:
- Beta-thalassemia minor is not associated with an increased risk of osteoporosis.
- Individuals with beta-thalassemia minor do not appear to have compromised bone health compared to the general population.